ArticleJournal of health economics and outcomes research2025

Size and Treatment Outcomes of HR+, HER2- Early Breast Cancer Population With High Risk of Recurrence: A Real-World Cohort Study With Danish Breast Cancer Cooperative Group Registry Data.

Heidi Loponen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.